vimarsana.com
Home
Live Updates
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Det
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Det
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant
Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LONDON, Jan. 14, 2022 /PRNewswire/
Related Keywords
United Kingdom ,
London ,
City Of ,
Nigel Lindner ,
Colleen Mcmillen ,
Exchange Commission ,
Drug Administration ,
Emergency Use Authorization ,
Chief Innovation Officer ,
Federal Food ,
Cosmetic Act ,
Lumiradx Platform ,
Securities Litigation Reform Act ,
Proxy Statement ,
Lumiradx ,
Analysis ,
Onfirms ,
Covid ,
Ntigen ,
Pest ,
Detects ,
Micron ,
Variant ,